Courage versus Fear: Keeping Health Risks in Perspective When the Dramatic and Rare Goes Culturally Viral
May 14th, 2013 |
6

It was a singular act of courage for Angelina Jolie to so openly reveal her fears and preventive double mastectomy. She just amazes, again and again. Along with admiration and sympathy for her, many will be hoping that this extends to greater understanding of the others in much the same boat as Jolie. All sorts [...]
Keep reading »Book Review: The Breast Cancer Checklist
October 11th, 2012 |
2

This is “Breast Cancer Awareness” month, the much-hyped recognition of a serious problem that we should be conscious of throughout the year. The associated “pink ribbon” campaign sometimes feels akin to a “Hallmark holiday” sales gimmick, rather than recognition of the pain of breast cancer and need for further research. Carmen Gonzalez just had a [...]
Keep reading »3-D Imaging Improves Breast Cancer Screening
November 13th, 2012 |
2

The mammograms most women receive are decidedly two-dimensional. An x-ray machine takes images of the breast from the sides, and radiologists examine the resulting image to see if it offers up any hits of potentially cancerous irregularities. These tests, however, are far from perfect. Normal calcium deposits and fibrous tissue can align to create a [...]
Keep reading »Routine Mammograms Lead to Overdiagnosis of Breast Cancer
April 2nd, 2012 |
1

Breast cancer kills nearly 40,000 women in the U.S. each year—a figure that has been in slow decline in the past two decades, despite (and in part thanks to) improved screening technology and an increase in treatment options. The percentage of women who get breast cancer and survive, however, is a trickier statistic to assess. [...]
Keep reading »Use of Avastin for Breast Cancer Nixed by FDA
November 18th, 2011 |
1

The multi-billion-dollar cancer drug Avastin is no longer an approved treatment for breast cancer treatment, per a long-anticipated announcement made Friday by the U.S. Food and Drug Administration (FDA). Avastin (bevacizumab, sold by Genentech/Roche) has been on the market since 2004 as a treatment for colon cancer. Following its lukewarm approval in 2008 for use [...]
Keep reading »Autism and mammography: Two stories of statistical confusion
November 10th, 2010 |
23

DENVER—There was substantial public outcry last year when new recommendations for mammograms came out suggesting that women could wait until age 50 to start breast cancer screening—and then only get screened every other year. Figures in support of the new policy were bandied about in the news and in doctors’ offices, regarding lives saved from [...]
Keep reading »As increasingly early puberty ups breast cancer risk, researchers search environment for clues
November 30th, 2009 |
2

NEW YORK—Women who reach puberty early have a higher risk of developing breast cancer than those who reach it late. So as the age of puberty’s onset among U.S. girls continues to drop, researchers are trying to figure out why—and how this growing risk factor might be avoided. Although mutations on BRCA genes can increase [...]
Keep reading »Government panel recommends fewer and later mammograms, no self-exams
November 17th, 2009 |
13

Most women would do fine to hold off until age 50 for their first mammograms and skip self-exams for breast lumps altogether, according to new government recommendations released Monday that came as a surprise to many in the medical community—and women in general. The report, issued by the U.S. Preventive Services Task Force and published [...]
Keep reading »Breast cancer deaths drop over past two decades
October 1st, 2009 |
2
.jpg)
The number of women who die from breast cancer has decreased slowly (about 2 percent per year) but steadily since 1990, according to a new report by the American Cancer Society (ACS), released to mark the start of Breast Cancer Awareness Month. Breast cancer is the most common cancer—other than skin cancer—for women in the [...]
Keep reading »








See what we're tweeting about





